Imatinib has a selective inhibitory effect on the Bcr-Abl tyrosine kinase enzyme, formed by the fusion of the Bcr gene and the Abl proto-oncogene (Abelson), at the cellular level, selectively suppresses proliferation and causes apoptosis of cell lines expressing Bcr-Abl tyrosine kinase, including immature leukemia cells produced in patients with Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
Read more- https://www.medixocentre.com/g....leevec-imatinib-pric

Epclusa is another hepatitis C direct-acting antiviral drug from the American company Gilead with sofosbuvir as the backbone. Patients with chronic hepatitis c must first undergo a systemic examination before taking Epclusa. Epclusa has little side effects but a high cure rate. You can check Epclusa cost here- https://www.medixocentre.com/epclusa-cost

Harvoni is a medicine containing the active substances ledipasvir and sofosbuvir in a single tablet. For the treatment of chronic (Long-term ) hepatitis C virus infection in adults and adolescents 12 to 18 years of age. Hepatitis C is a virus that infects the liver. The active substances in the drug work together by blocking two different proteins that the virus needs to grow and reproduce itself, thereby permanently eliminating the infection from the body. Harvoni is sometimes taken with another drug, ribavirin. Harvoni cost in USA is quite high.
Click here to know more.
https://www.medixocentre.com/harvoni-cost